Opportunity Information: Apply for PAR 09 162
Apply for PAR 09 162
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Nov 23, 2011 and posted on Jun 11, 2009.
- Applicants must submit their applications by Nov 28, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) is a National Cancer Institute (NCI) funding opportunity designed to strengthen diversity in the basic cancer biology research workforce. Issued jointly by the Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), the program invites applications from investigators from diverse populations who want to pursue research focused on fundamental questions in cancer biology. The underlying premise is that the basic cancer research field benefits when talented scientists from all backgrounds are recruited, supported, and retained, because broader representation helps expand perspectives, influences how research priorities are set, and ultimately increases the number of basic cancer researchers from underrepresented groups.
This opportunity uses the NIH Exploratory/Developmental Grant mechanism (R21), which is typically intended for early-stage, high-impact, or developmental projects that may be less mature than a full R01 application. A central goal here is to serve as a bridge for investigators who have completed their training and are transitioning into more independent research careers, but may need additional time and support to generate preliminary data, refine their ideas, and become competitive for a larger, more comprehensive R01 proposal. In other words, it is positioned as both a scientific launchpad for basic cancer biology projects and a career-development stepping stone aimed at improving representation in the cancer research pipeline.
Funding under this announcement is discretionary and depends on the availability of appropriated funds, meaning awards are not guaranteed even if applications are meritorious. The announcement is identified as PAR-09-162 and is associated with CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.396 (Cancer Biology Research). There is no cost sharing or matching requirement, which reduces the financial barrier for applicant institutions.
Eligibility is broad across the research and higher education landscape and includes private institutions of higher education, public and state-controlled institutions of higher education, state governments, and nonprofit organizations (including those with and without 501(c)(3) status, as specified). The announcement also explicitly highlights additional eligible applicant categories that align with the diversity mission, including Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and eligible federal agencies. This eligibility framing reinforces the program objective of engaging institutions and environments that may be more likely to support or employ investigators from underrepresented backgrounds.
From an administrative standpoint, the opportunity was posted June 11, 2009, with later record updates showing a creation date of November 23, 2011. The original closing date is listed as November 23, 2011, with a current closing date of November 28, 2011, and an archive date of December 29, 2011. The full announcement was made available through the NIH grants guide (linked in the source), and applicants who experienced access issues were directed to contact the NIH Office of Extramural Research (OER) webmaster.
Frequently Asked Questions (FAQs)
What is the Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)?
This is a National Cancer Institute (NCI) funding opportunity that uses the NIH Exploratory/Developmental Grant mechanism (R21). It is designed to strengthen diversity in the basic cancer biology research workforce by supporting research projects that focus on fundamental questions in cancer biology.
Which NCI components issued this funding opportunity?
The opportunity was issued jointly by the Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB).
What is the main purpose of this program?
The primary purpose is to promote workforce diversity in basic cancer research by inviting applications from investigators from diverse populations who want to pursue research on fundamental questions in cancer biology. The premise described in the announcement is that broader representation strengthens the field by expanding perspectives, influencing research priority-setting, and increasing the number of basic cancer researchers from underrepresented groups.
What type of research does this grant support?
The program supports research focused on fundamental (basic) questions in cancer biology. The description emphasizes basic cancer biology rather than applied, clinical, or other research areas.
What does the R21 mechanism mean in the context of this opportunity?
The R21 is described as an exploratory/developmental mechanism typically intended for early-stage, high-impact, or developmental projects that may be less mature than a full R01 application. Within this opportunity, it is positioned as a scientific launchpad for basic cancer biology projects and as a stepping stone toward a future R01.
Is this grant intended to help investigators move toward an R01?
Yes. A central goal is to serve as a bridge for investigators who have completed their training and are transitioning into more independent research careers, but may need additional time and support to generate preliminary data, refine their ideas, and become competitive for a larger R01 proposal.
Are awards guaranteed if an application is strong?
No. Funding under this announcement is described as discretionary and dependent on the availability of appropriated funds, meaning awards are not guaranteed even for meritorious applications.
What is the funding opportunity announcement (FOA) number?
The announcement identifier provided is PAR-09-162.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA 93.393 (Cancer Cause and Prevention Research) and 93.396 (Cancer Biology Research).
Is cost sharing or matching required?
No. The information provided states there is no cost sharing or matching requirement.
What types of organizations are eligible to apply?
Eligibility is described as broad and includes private institutions of higher education, public and state-controlled institutions of higher education, state governments, and nonprofit organizations (including those with and without 501(c)(3) status, as specified in the announcement summary).
Are specific institution types highlighted as eligible?
Yes. The opportunity explicitly highlights additional eligible applicant categories aligned with the diversity mission, including Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and eligible federal agencies.
Does the eligibility framing connect to the diversity objective?
Yes. The summary indicates that highlighting these eligible applicant categories reinforces the objective of engaging institutions and environments that may be more likely to support or employ investigators from underrepresented backgrounds.
When was the opportunity posted?
The opportunity was posted on June 11, 2009.
Why do the records show a later creation date as well?
The administrative information provided indicates later record updates showing a creation date of November 23, 2011.
What are the listed closing dates for this opportunity?
The original closing date is listed as November 23, 2011, and the current closing date is listed as November 28, 2011.
When was the opportunity archived?
The archive date provided is December 29, 2011.
Where was the full announcement made available?
The information provided states that the full announcement was made available through the NIH grants guide (linked in the source material for the opportunity).
Who should be contacted if there are access issues with the announcement?
Applicants who experienced access issues were directed to contact the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same category: Education Health
Next opportunity: Striving Readers CFDA 84.371
Previous opportunity: International Food Relief Partnerships (IFRP) Commodity Grant Program RFA 2010 DCHA/FFP
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 09 162
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 09 162) also looked into and applied for these:
| Funding Opportunity |
|---|
| Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20) Apply for PAR 09 201 Funding Number: PAR 09 201 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) Apply for PA 09 208 Funding Number: PA 09 208 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cutting Edge Basic Research Awards (CEBRA) (R21) Apply for PAR 09 222 Funding Number: PAR 09 222 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) (U01) Apply for RFA CA 09 025 Funding Number: RFA CA 09 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Early Detection Research Network Biomarker Developmental Laboratories (U01) Apply for RFA CA 09 017 Funding Number: RFA CA 09 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $400,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows in Nursing Research (F31) Apply for PAR 09 227 Funding Number: PAR 09 227 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms Underlying the Links between Psychosocial Stress, Aging, the Brain and the Body (R01) Apply for PA 09 216 Funding Number: PA 09 216 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diet, Epigenetic Events, and Cancer Prevention (R01) Apply for PA 09 234 Funding Number: PA 09 234 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diet, Epigenetic Events, and Cancer Prevention (R21) Apply for PA 09 235 Funding Number: PA 09 235 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) Apply for PA 09 236 Funding Number: PA 09 236 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) Apply for PA 09 237 Funding Number: PA 09 237 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis (R21) Apply for PA 09 238 Funding Number: PA 09 238 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Behavioral Science Track Award for Rapid Transition (B/START) (R03) Apply for PAR 09 239 Funding Number: PAR 09 239 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Detection Research Network Clinical Validation Centers (U01) Apply for RFA CA 09 018 Funding Number: RFA CA 09 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $600,000 |
| The Early Detection Research Network Biomarker Reference Laboratories (U24) Apply for RFA CA 09 019 Funding Number: RFA CA 09 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Early Detection Research Network Data Management and Coordinating Center and Statistics and Biomarker Resource Center (U24) Apply for RFA CA 09 020 Funding Number: RFA CA 09 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Support for Human Specimen Banking in NCI Supported Clinical Trials Cooperative Group Banks (CGB) (U24) Apply for RFA CA 09 504 Funding Number: RFA CA 09 504 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse among U.S. Military Personnel, Veterans and their Families (R01) Apply for RFA DA 10 001 Funding Number: RFA DA 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Substance Use and Abuse among U.S. Military Personnel, Veterans and their Families (R21) Apply for RFA DA 10 002 Funding Number: RFA DA 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NIMH Career Transition Award for Intramural Investigators (K22) Apply for PAR 09 246 Funding Number: PAR 09 246 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 162", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.